apollo
logo
0Login
Introducing Our Latest Arrival!
Emrolfin 0.25%W/W Cream 50gm

Emrolfin 0.25%W/W Cream 50gm

Consult Doctor

Consume Type

TOPICAL

Return Policy

Not Returnable

Expires on or after

Apr-24

About Emrolfin 0.25%W/W Cream 50gm

Emrolfin 0.25%W/W Cream 50gm belongs to a class of drugs called 'antifungal' primarily used to treat fungal nail infections. Fungal infection occurs when a fungus invades and affects the tissue on the skin.  Symptoms of a fungal infection include skin rash, irritation, redness, and scaling of the skin.  

Emrolfin 0.25%W/W Cream 50gm contains 'Amorolfine' that works by stopping producing a chemical called 'ergosterol' in fungi that causes nail infection. Without ergosterol, the fungus cannot survive. As a result, infection-causing fungi die. 

Use Emrolfin 0.25%W/W Cream 50gm as suggested by your doctor. Common side effects of Emrolfin 0.25%W/W Cream 50gm may include dry skin, itching, redness, or burning sensation of the skin. Most of these side effects of Emrolfin 0.25%W/W Cream 50gm do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are pregnant or a nursing mother, it is advised to consult a doctor before using Emrolfin 0.25%W/W Cream 50gm. If you use Emrolfin 0.25%W/W Cream 50gm in topical form, avoid smoking or going near naked flames as Emrolfin 0.25%W/W Cream 50gm catches fire and burns easily. If you are using any steroidal cream, lotion or ointment, inform your doctor before taking Emrolfin 0.25%W/W Cream 50gm to adjust the dose.

Uses of Emrolfin 0.25%W/W Cream 50gm

Fungal nail infection

Key Benefits

Emrolfin 0.25%W/W Cream 50gm is an antifungal that is primarily used to treat fungal infections of nails and skin such as ringworm, jock itch and athlete’s foot, seborrheic dermatitis (dry, flaky skin on face, scalp, chest, upper back, or ears) and pityriasis (a type of skin rash that causes scaly, discoloured patches on chest, back, legs and arms). The fungal cell membranes are essential for their survival as they prevent unwanted substances into the cells and stop the leakage of cell contents. Emrolfin 0.25%W/W Cream 50gm causes holes in the fungal cell membranes and kills fungi. Thereby, clears fungal infection and provides relief from cracking, burning, scaling and itching of the skin caused due to infections. 

Directions for Use

Avoid contact of Emrolfin 0.25%W/W Cream 50gm with nose, mouth, or eyes. In case if it comes in contact with these areas accidentally, rinse with water thoroughly.Cream/Gel/Lotion: Wash and dry the infected area of the skin. Take a small amount on the finger and gently rub it on the clean and dry affected area and surrounding skin.Nail lacquer: File the infected area of the nail. Then gently clean the surface of the nail. Take some lacquer from the bottle with the help of the spatula. Apply the medicine over the entire surface of the nail. Again clean the spatula and keep it for reuse.Spray: Please read the instructions leaflet provided with the pack. Use the spray as suggested by the doctor.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Emrolfin 0.25%W/W Cream 50gm

  • Itching
  • Dry skin
  • Redness
  • Burning sensation of the skin

Drug Warnings

Before using Emrolfin 0.25%W/W Cream 50gm, let your doctor know if you have a history of liver diseases, adrenal gland problems, cataract, glaucoma, diabetes or allergic reactions to any medicine ingredient. Let your doctor know if you plan to become pregnant or already pregnant and a lactating mother. Studies show that there may be harmful effects on the baby; hence Emrolfin 0.25%W/W Cream 50gm should be used with caution in pregnancy under your doctor's supervision. If you apply Emrolfin 0.25%W/W Cream 50gm to breasts or nipple for treatment, wash it off while nursing your baby. Emrolfin 0.25%W/W Cream 50gm is for external use only, so avoid contact with the eyes, the mouth, or intravaginally. Notify the doctor if there is no improvement after one week of treatment for tinea cruris or tinea corporis or two weeks for tinea pedis. When using Emrolfin 0.25%W/W Cream 50gm in the groin area, patients should use the medication for two weeks only. Prolonged use of Emrolfin 0.25%W/W Cream 50gm may cause hormonal suppression, Cushing's syndrome, hyperglycemia (increased blood sugar level), and glucosuria (high sugar in urine) in some patients. Apply sunscreen (SPF 30 or higher) whenever you go outdoor in the sunlight. 

Drug Interactions

Drug-Drug Interaction: Emrolfin 0.25%W/W Cream 50gm may interact with respiratory-related medicines (budesonide, formoterol), drugs treating HIV/AIDS (ritonavir, cobicistat) and corticosteroids.

Drug-Food Interaction: No drug-food interactions found/established.

Drug-Disease Interaction: Emrolfin 0.25%W/W Cream 50gm should not be given in patients with a history of allergic reactions to clotrimazole and betamethasone, have diabetes, liver diseases, cataract, glaucoma, adrenal gland problems, and hormonal problems.

Drug-Drug Interactions Checker List

  • BUDESONIDE
  • FORMOTEROL
  • COBICISTAT
  • RITONAVIR

Habit Forming

No

Diet & Lifestyle Advise

  • Always wear loose-fitting clothes to avoid further sweat and spread of the fungal infection.
  • In wet places such as changing rooms and gym showers, don’t walk on barefoot to prevent fungal infections.
  • Regularly change your socks and wash your feet. Avoid shoes that make your feet sweaty and hot.
  • Regularly change your socks and wash your feet. Avoid shoes that make your feet sweaty and hot.
  • Do not walk barefoot at places like gym showers to prevent fungal infections.
  • Do not scratch the affected area of skin as it can spread the infection to other body parts.
  • Avoid sharing towels, combs, bedsheets, shoes or socks with others.
  • Wash your bedsheets and towels regularly.
  • Follow a candida diet if you suffer from vaginal yeast infection. Candida diet excludes high sugary foods, some dairy products and foods with artificial preservatives.
  • Avoid or limit the intake of alcohol and caffeine.

Special Advise

It is advised to reach out to your doctor if the fungal infection symptoms persist or worsen after two treatment weeks. Before applying Emrolfin 0.25%W/W Cream 50gm, clean and dry the affected area. Avoid contact of Emrolfin 0.25%W/W Cream 50gm with nose, mouth or eyes. If Emrolfin 0.25%W/W Cream 50gm comes in contact with these areas accidentally, rinse with water thoroughly. Do not wash the treated areas for a minimum of 3 hours after you apply Emrolfin 0.25%W/W Cream 50gm. 

Disease/Condition Glossary

Fungal infection is a skin disease in which a fungus attacks the tissue and cause infection. Fungal infections may be contagious (spread from one person to another). Ringworm is a common fungal infection of skin or scalp contagious and causes a rash resembling a worm in a ring shape. Jock itch (also known as tinea cruris) is a fungal infection of the skin that causes an itchy, red rash in warm and moist areas of the body such as the groin, buttocks, and inner thighs. Athlete’s foot (also known as tinea pedis) is a fungal infection that usually starts between the toes, especially in people who have extremely sweaty feet and wear tight-fitting shoes. It occurs most commonly in athletes. It causes itching, burning, or stinging sensation due to a scaly rash. Seborrheic dermatitis is a skin condition that causes an itchy rash with dry, flaky scales on the skin that contains oil glands such as the scalp, face, back, and upper chest.  Fungal infection in nails happens when there is an overgrowth of fungi in, under, or on the nail. Fungal infections usually occur in toenails than fingernails, likely because toes remain under shoes, in a warm, moist environment. 

Country of origin

India

Manufacturer/Marketer address

A-23, Sector 9, Noida-201301
Other Info - EMR0010

FAQs

Emrolfin 0.25%W/W Cream 50gm is safe to use with doctor’s advice and over a limited period (1-2 weeks). Let your doctor know if your symptoms are not relieved by then or experience any side effects.
Emrolfin 0.25%W/W Cream 50gm consists of Amorolfine that should be used after consulting with doctor if a person has raised blood sugar levels (diabetes mellitus).
You are required to maintain at least a three-hour gap after application of Emrolfin 0.25%W/W Cream 50gm if you are using more than one topical medicine.
No, do not stop taking Emrolfin 0.25%W/W Cream 50gm on your own even if the symptoms are relieved until your course advised by the doctor is finished.
There is limited data on how Emrolfin 0.25%W/W Cream 50gm affects breastfeeding. Please consult your doctor before starting Emrolfin 0.25%W/W Cream 50gm. However, if nursing mothers apply Emrolfin 0.25%W/W Cream 50gm to their breasts for treatment, it is advised to wash the affected area thoroughly before breastfeeding the baby.
Emrolfin 0.25%W/W Cream 50gm contains 'Amorolfine' that works by stopping producing a chemical called 'ergosterol' in fungi that causes nail infection. Without ergosterol, the fungus cannot survive. As a result, infection-causing fungi die. 
Emrolfin 0.25%W/W Cream 50gm is for topical (for skin) use only. Do not put bandage or dressing on the affected area while treating with Emrolfin 0.25%W/W Cream 50gm unless the doctor advised. If the medicine gets into your eyes, nose, mouth or vagina, rinse with cold water. Do not apply Emrolfin 0.25%W/W Cream 50gm on open wounds, lesions and blisters.
Emrolfin 0.25%W/W Cream 50gm, when used for longer periods, can cause thinning and weakening of the skin. Please stop using Emrolfin 0.25%W/W Cream 50gm and immediately consult your doctor if you notice these symptoms.
Yes, fungal infection is a contagious skin condition which spreads from one person to another through direct skin to skin contact or by contact with contaminated soil or surfaces and infected animals. Therefore, it is recommended to avoid close direct contact until the infection is clear and avoid sharing things with the infected person as it can also spread the infection.
You are recommended to apply makeup or sunscreen to the treated area of skin after a minimum of 20 minutes of using Emrolfin 0.25%W/W Cream 50gm.
You are recommended to use Emrolfin 0.25%W/W Cream 50gm for as long as your doctor has prescribed it. However, if the condition worsens or persists after 2 to 4 weeks of treatment with Emrolfin 0.25%W/W Cream 50gm, please consult a doctor.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Safe if prescribed

No interaction found/ established. Please consult your doctor before using Emrolfin 0.25%W/W Cream 50gm.

bannner image

Pregnancy

Caution

Emrolfin 0.25%W/W Cream 50gm is Category C pregnancy drug and is given to a pregnant woman only if the doctor thinks benefits outweigh risks.

bannner image

Breast Feeding

Unsafe

There is limited data on how Emrolfin 0.25%W/W Cream 50gm affects breastfeeding. Please consult your doctor before starting Emrolfin 0.25%W/W Cream 50gm. However, if nursing mothers apply Emrolfin 0.25%W/W Cream 50gm to their breasts for treatment, it is advised to wash the affected area thoroughly before breastfeeding the baby.

bannner image

Driving

Safe if prescribed

Emrolfin 0.25%W/W Cream 50gm does not influence on the ability to drive or use machines.

bannner image

Liver

Caution

If you have any concerns regarding the use of Emrolfin 0.25%W/W Cream 50gm in patients with Liver problems, please consult a doctor.

bannner image

Kidney

Safe if prescribed

Emrolfin 0.25%W/W Cream 50gm is safe for patients with kidney disease if prescribed by a doctor.

bannner image

Children

Safe if prescribed

Emrolfin 0.25%W/W Cream 50gm is to be used on children below 12 years of age only when prescribed by the doctor.

Add to Cart